San Diego, CA, November 22-23, 2024 — Dr. Jing-feng Huang, the founder of Seinda Pharmaceutical Corp., attended the Ophthalmology Innovation Summit XIV and, as an invited presenter, presented the positive results from the Phase 2 clinical trial of SY-201 Ophthalmic solution for the treatment of dry eye disease conducted in the United States.

The top-line results of the study have been published on https://clinicaltrials.gov/, for further information, please contact Info@SeindaPharm.com